Combining brain imaging with microarray: Isolating molecules underlying the physiologic disorders of the brain

Aimee Pierce, Scott A. Small

Research output: Contribution to journalReview article

9 Citations (Scopus)

Abstract

Many diseases of the nervous system cause dysfunction by impairing neuronal physiology more than by altering brain anatomy - including age-related cognitive decline, most psychiatric disorders, and even the earliest stages of Alzheimer's disease. The absence of clear anatomical markers makes it difficult to identify targeted cells, which in turn impedes attempts to isolate the pathogenic molecules that cause physiologic disruption. Here we show how brain imaging and microarray can be used as complimentary techniques that together can characterize the cellular and molecular aspects of this class of diseases.

Original languageEnglish (US)
Pages (from-to)1145-1152
Number of pages8
JournalNeurochemical Research
Volume29
Issue number6
DOIs
StatePublished - Jun 1 2004
Externally publishedYes

Fingerprint

Brain Diseases
Microarrays
Nervous System Diseases
Neuroimaging
Psychiatry
Brain
Anatomy
Alzheimer Disease
Imaging techniques
Molecules
Physiology
Neurology
Cognitive Dysfunction

Keywords

  • Alzheimer's disease
  • Brain anatomy
  • Neuronal physiology
  • Pathogenic molecules

ASJC Scopus subject areas

  • Biochemistry
  • Cellular and Molecular Neuroscience

Cite this

Combining brain imaging with microarray : Isolating molecules underlying the physiologic disorders of the brain. / Pierce, Aimee; Small, Scott A.

In: Neurochemical Research, Vol. 29, No. 6, 01.06.2004, p. 1145-1152.

Research output: Contribution to journalReview article

@article{354a95c063684643a495de03c3b46d2f,
title = "Combining brain imaging with microarray: Isolating molecules underlying the physiologic disorders of the brain",
abstract = "Many diseases of the nervous system cause dysfunction by impairing neuronal physiology more than by altering brain anatomy - including age-related cognitive decline, most psychiatric disorders, and even the earliest stages of Alzheimer's disease. The absence of clear anatomical markers makes it difficult to identify targeted cells, which in turn impedes attempts to isolate the pathogenic molecules that cause physiologic disruption. Here we show how brain imaging and microarray can be used as complimentary techniques that together can characterize the cellular and molecular aspects of this class of diseases.",
keywords = "Alzheimer's disease, Brain anatomy, Neuronal physiology, Pathogenic molecules",
author = "Aimee Pierce and Small, {Scott A.}",
year = "2004",
month = "6",
day = "1",
doi = "10.1023/B:NERE.0000023601.50101.7f",
language = "English (US)",
volume = "29",
pages = "1145--1152",
journal = "Neurochemical Research",
issn = "0364-3190",
publisher = "Springer New York",
number = "6",

}

TY - JOUR

T1 - Combining brain imaging with microarray

T2 - Isolating molecules underlying the physiologic disorders of the brain

AU - Pierce, Aimee

AU - Small, Scott A.

PY - 2004/6/1

Y1 - 2004/6/1

N2 - Many diseases of the nervous system cause dysfunction by impairing neuronal physiology more than by altering brain anatomy - including age-related cognitive decline, most psychiatric disorders, and even the earliest stages of Alzheimer's disease. The absence of clear anatomical markers makes it difficult to identify targeted cells, which in turn impedes attempts to isolate the pathogenic molecules that cause physiologic disruption. Here we show how brain imaging and microarray can be used as complimentary techniques that together can characterize the cellular and molecular aspects of this class of diseases.

AB - Many diseases of the nervous system cause dysfunction by impairing neuronal physiology more than by altering brain anatomy - including age-related cognitive decline, most psychiatric disorders, and even the earliest stages of Alzheimer's disease. The absence of clear anatomical markers makes it difficult to identify targeted cells, which in turn impedes attempts to isolate the pathogenic molecules that cause physiologic disruption. Here we show how brain imaging and microarray can be used as complimentary techniques that together can characterize the cellular and molecular aspects of this class of diseases.

KW - Alzheimer's disease

KW - Brain anatomy

KW - Neuronal physiology

KW - Pathogenic molecules

UR - http://www.scopus.com/inward/record.url?scp=3142693899&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3142693899&partnerID=8YFLogxK

U2 - 10.1023/B:NERE.0000023601.50101.7f

DO - 10.1023/B:NERE.0000023601.50101.7f

M3 - Review article

C2 - 15176471

AN - SCOPUS:3142693899

VL - 29

SP - 1145

EP - 1152

JO - Neurochemical Research

JF - Neurochemical Research

SN - 0364-3190

IS - 6

ER -